Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients

NCT00819052 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

445

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Nevirapine XR
DRUG: Nevirapine XR
DRUG: Nevirapine IR

Sponsor

Boehringer Ingelheim